Valneva (VALN)
NASDAQ:VALN

Valneva Stock Analysis & Ratings

Valneva Stock Analysis Overview

Smart Score
9
Outperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Valneva stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

VALN

VALN Stock Stats

Previous Close$37.66
Open$36.11
Bid0 x 0
Ask0 x 0
Today’s Range$34.83 - $36.17
52-Week Range$24.16 - $67.84
Volume82.64K
Average Volume108.27K
Market Cap$1.86B
Beta4.97
P/E Ratio-15.3
EPS-2.30
Earnings DateMar 24, 2022

Company Description

Valneva

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travellers; one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) for the prevention of cholera and diarrhoea. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, and third-party products; Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; and Technologies and services which relates to services and inventions at a commercialization stage. The group is based in France and operates internationally.
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas Lingelbach
Employees
532
Website
http://www.valneva.com
ISIN
US92025Y1038
Address
6 rue Alain Bombard, Saint-Herblain, 44800, FR

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

VALN FAQ

What was Valneva’s price range in the past 12 months?
Valneva lowest stock price was $24.16 and its highest was $67.84 in the past 12 months.
    What is Valneva’s market cap?
    Valneva’s market cap is $1.86B.
      What is Valneva’s price target?
      The average price target for Valneva is $50.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $70.00 ,the lowest forecast is $31.00. The average price target represents 42.86% Increase from the current price of $35.35.
        What do analysts say about Valneva?
        Valneva’s analyst rating consensus is a ‘Hold. This is based on the ratings of 2 Wall Streets Analysts.
          When is Valneva’s upcoming earnings report date?
          Valneva’s upcoming earnings report date is Mar 24, 2022 which is in 59 days.
            How were Valneva’s earnings last quarter?
            Valneva released its earnings results on Nov 18, 2021. The company reported -$1.021 earnings per share for the quarter, missing the consensus estimate of $1.554 by -$2.575.
              Is Valneva overvalued?
              According to Wall Street analysts Valneva’s price is currently Undervalued.
                Does Valneva pay dividends?
                Valneva does not currently pay dividends.
                What is Valneva’s EPS estimate?
                Valneva’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Valneva have?
                Valneva has 52,530,000 shares outstanding.
                  What happened to Valneva’s price movement after its last earnings report?
                  Valneva reported an EPS of -$1.021 in its last earnings report, missing expectations of $1.554. Following the earnings report the stock price went up 2.903%.
                    Which hedge fund is a major shareholder of Valneva?
                    Currently, no hedge funds are holding shares in VALN

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis